IRCT20231119060107N1 IRCT 2024-01-08 Tehran University of Medical Sciences The Efficacy of oral dutasteride in the treatment of female pattern androgenetic alopecia The Efficacy and side effects of oral dutasteride in the treatment of female pattern androgenetic alopecia compared with oral spironolactone in one sided clinical trial 2024-02-19 anticipated 40 Complete https://irct.ir/trial/73892 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: block randomization we have Ten envelopes (blocks) Each envelope containing four papers (two Dutasteride, two spironolactone) to determine every new patient's group, an envelope is selected randomly then a paper is randomly picked from the envelope which determines whether the patient will be in the study group or control group, Blinding description: The principal investigator who is responsible for grading the degree of baldness before and after treatment to photographic images and analysis of tricoscopy images is not aware of the medication used by the patient. 3 Androgenitic alopecia. Intervention 1: Intervention group: patients prescribed oral dutasteride 0.5 mg per day for 6 months. Intervention 2: Control group: patients prescribed oral spironolactone 100 mg per day for 6 months. Yes - There is a plan to make this available What will be shared: Fotofinder and photography gallery in razi center When: After completing the study and for one year To whom: Razi hospital residents and other recearch centers students Conditions: For research purposes and with respect to patiensts privacy Where to obtain: Dr ifa itesami Ifa.etesami@gmail.com How to obtain: Contact razi hospital research center Ifa.etesami@gmail.com Comments: